Etomidate (ETM)
Etomidate is a short acting intravenous anaesthetic agent used for the induction of general anaesthesia and for sedation for short procedures such as reduction of dislocated joints, tracheal intubation and cardioversion. Etomidate is prepared by the following procedure. It illustrates a special case of obtaining derivatives of imidazole by interaction of α-aminocarbonyl compounds with thiocyanates. The reaction of α-methylbenzylamine with ethyl chloroacetate gives N-ethoxycarbonylmethyl-N-1-phenylethylamine, which undergoes further formylation by formic acid. The resulting N-ethoxycarbonylmethyl-N-formyl-N-1-phenylethylamine undergoes further C-formylation by ethyl formate in the presence of sodium ethoxide. Etomidate is highly protein bound in blood plasma and is metabolised by hepatic and plasma esterases to inactive products. It exhibits a bi-exponential decline.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Etomidate (ETM) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Etomidate (ETM) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Etomidate (ETM) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Etomidate (ETM) CLIA Kit Customized Service Offer
n/a ELISA Kit for Etomidate (ETM) ELISA Kit Customized Service Offer